Could Decreased Reporting of Suspected Adverse Reactions Generate Future Safety Concerns?
作者信息
Ferrara Francesco, Mancaniello Carolina, Nava Livia, Salierno Alessandra, Casillo Raffaele, Trama Ugo, Nava Eduardo, Vitiello Antonio
机构信息
Asl Napoli 3 Sud, Nola, Naples, Italy.
Asl Napoli 2 Nord, Frattamaggiore, Naples, Italy.
出版信息
Hosp Pharm. 2022 Aug;57(4):419-421. doi: 10.1177/00185787211069040. Epub 2022 Jan 7.
Abstract
摘要
相似文献
1
Could Decreased Reporting of Suspected Adverse Reactions Generate Future Safety Concerns?疑似不良反应报告的减少会引发未来的安全担忧吗？
Hosp Pharm. 2022 Aug;57(4):419-421. doi: 10.1177/00185787211069040. Epub 2022 Jan 7.
2
[A retrospective pharmacovigilance analysis: could decreased reporting of suspected adverse reactions generate future safety concerns?].[一项回顾性药物警戒分析：疑似不良反应报告率下降会引发未来的安全担忧吗？]
Recenti Prog Med. 2022 Mar;113(3):198-201. doi: 10.1701/3761.37485.
3
Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories.澳大利亚直接全科医生报告药物不良反应的持续下降和澳大利亚安全建议报告中细节的缺乏。
Drug Saf. 2023 Jul;46(7):703-710. doi: 10.1007/s40264-023-01321-4. Epub 2023 Jun 2.
4
[Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005].[2004年1月1日至2005年12月31日德国依据《德国感染保护法》和《德国药品法》进行免疫接种后的药物不良反应]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 Nov;50(11):1404-17. doi: 10.1007/s00103-007-0368-6.
5
Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.1969 - 2002年美国药品不良事件监测与药物撤市：报告疑似不良反应的重要性
Arch Intern Med. 2005 Jun 27;165(12):1363-9. doi: 10.1001/archinte.165.12.1363.
6
Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System.疑似与乳腺癌化疗相关的药物不良反应：巴西自发报告系统的不成比例性分析
Front Pharmacol. 2019 May 8;10:498. doi: 10.3389/fphar.2019.00498. eCollection 2019.
7
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况：文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
8
Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.全球儿童疑似药物不良反应报告：使用 VigiBase 的探索性研究。
Drug Saf. 2011 May 1;34(5):415-28. doi: 10.2165/11587540-000000000-00000.
9
Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.意大利英夫利昔单抗原研药与生物类似药的实际应用模式和安全性特征的真实世界数据：一项多区域研究。
BioDrugs. 2018 Dec;32(6):607-617. doi: 10.1007/s40259-018-0313-2.
10
Allergic reactions to Japanese encephalitis vaccine.对日本脑炎疫苗的过敏反应。
Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. doi: 10.1016/s0889-8561(03)00102-4.
引用本文的文献
1
Comparison and Analysis of Antibiotic Consumption in Two Italian Hospital Settings in Relation to the Fight of Antimicrobial Resistance.意大利两家医院环境中抗生素使用情况与抗菌药物耐药性斗争的比较与分析
Pharmaceuticals (Basel). 2024 Jan 30;17(2):183. doi: 10.3390/ph17020183.
2
The diabetic patient between sustainability and effectiveness of new treatments.糖尿病患者在新治疗方法的可持续性与有效性之间的情况。
J Diabetes Metab Disord. 2023 Sep 16;22(2):1635-1643. doi: 10.1007/s40200-023-01296-0. eCollection 2023 Dec.
本文引用的文献
1
COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view.2019冠状病毒病大流行：疫苗与新型单克隆抗体，观点
Ir J Med Sci. 2022 Feb;191(1):487-488. doi: 10.1007/s11845-021-02584-5. Epub 2021 Mar 12.
2
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2.COVID-19 作为一种全球大流行病的出现：了解 SARS-CoV-2 的流行病学、免疫反应和潜在的治疗靶点。
Biochimie. 2020 Dec;179:85-100. doi: 10.1016/j.biochi.2020.09.018. Epub 2020 Sep 22.
3
[Case-non case studies: Principles, methods, bias and interpretation].[病例-非病例研究：原理、方法、偏差与解读]
Therapie. 2018 May-Jun;73(3):247-255. doi: 10.1016/j.therap.2017.08.006. Epub 2017 Oct 31.
4
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database.药物警戒数据库中用于识别药物不良反应的不成比例性分析的益处与优势。
Br J Clin Pharmacol. 2011 Dec;72(6):905-8. doi: 10.1111/j.1365-2125.2011.04037.x.
Zotero 插件